Firebrick Pharma Limited (AU:FRE) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Firebrick Pharma Limited has successfully completed its Share Purchase Plan, raising $635,600 with the participation of around 100 shareholders, and anticipates an additional $158,700 from a Shortfall Placement. The capital raised, alongside recent RDTI funds, will be used to expand marketing for the company’s Nasodine® Nasal Spray in Singapore and the US, targeting healthcare professionals, pharmacy distributions, and marketing partnerships.
For further insights into AU:FRE stock, check out TipRanks’ Stock Analysis page.